Willingness to take less medication for type 2 diabetes among older patients: The Diabetes & Aging Study

Abstract

AbstractBackgroundTo examine the willingness of older patients to take less diabetes medication (de‐intensify) and to identify characteristics associated with willingness to de‐intensify treatment.MethodsSurvey conducted in 2019 in an age‐stratified, random sample of older (65–100 years) adults with diabetes on glucose‐lowering medications in the Kaiser Permanente Northern California Diabetes Registry. We classified survey responses to the question: “I would be willing to take less medication for my diabetes” as willing, neutral, or unwilling to de‐intensify. Willingness to de‐intensify treatment was examined by several clinical characteristics, including American Diabetes Association (ADA) health status categories used for individualizing glycemic targets. Analyses were weighted to account for over‐sampling of older individuals.ResultsA total of 1337 older adults on glucose‐lowering medication(s) were included (age 74.2 ± 6.0 years, 44% female, 54.4% non‐Hispanic white). The proportions of participants willing, neutral, or unwilling to take less medication were 51.2%, 27.3%, and 21.5%, respectively. Proportions of willing to take less medication varied by age (65–74 years: 54.2% vs. 85+ years: 38.5%) and duration of diabetes (0–4 years: 61.0% vs. 15+ years: 44.2%), both p < 0.001. Patients on 1–2 medications were more willing to take less medication(s) compared with patients on 10+ medications (62.1% vs. 46.6%, p = 0.03). Similar proportions of willingness to take less medications were seen across ADA health status, and HbA1c. Willingness to take less medication(s) was similar across survey responses to questions about patient‐clinician relationships.ConclusionsClinical guidelines suggest considering treatment de‐intensification in older patients with longer duration of diabetes, yet patients with these characteristics are less likely to be willing to take less medication(s).